Utilization of Drug Information Systems by Medical Representatives in the Japanese Pharmaceutical Industry
Tóm tắt
For full utilization of a drug information database system by users, education and support activities are indispensable. Daiichi Pharmaceutical Co., Ltd. ’s PMS Administration Department has facilitated familiarization of users with its in-house database systems and improved their utilization through an in-house training campaign, analysis of information retrieved (log files), feedback on the results, on-screen information services on the updated databases, contributions to in-house publications, and so forth. Through these activities to facilitate familiarization with and utilization of the database, medical representatives (MRs) accessing databases increased from 44% to 80% over four years. This report presents activities to improve the utilization of Daiichi Pharmaceutical’s databases by MRs and some examples.
Tài liệu tham khảo
Takahashi H, Uraki K, Haraguchi N, et al. Eisai product literature information system. J Inform Proc Manage. 1981;24:825–832.
Kitaguchi T, Nojiri T, Suzuki S, et al. EDPS of clinical case record and scientific document in the industry post-marketing surveillance of drugs. Meth Inform Med. 1983;22:135–148.
Yanagida T. Case study/Fujisawa Pharmaceutical Co., Ltd. building an information retrieval system easily operated by mouse. Nikkei Computer. 1992;224–234.
Sigemura K, Kawaguchi T, Nakata A, et al. Construction of the database on the Internet concerning Q & A about medical drugs. Proceedings of the 16th Joint Conference on Medical Information, Chiba. 1996;718–719.
Koyama A, Sato K. Approach to a literature database for own products “JSAMD.” J Inf Sci Tech Ass. 1993;42(10):909–910.
Wada S, Akimoto Y, Takakura H, et al. Building of a medical information system, MAPS. Proceedings of the 33rd meeting of the Information Science Technology Association. 1996;123–126.
Tomonaga F, Kasanuki H, Kamashiro T, et al. Study for Health and Welfare Science. 1990–1991. A study and general report on the functions of medical representatives in the pharmaceutical industry. For appropriate medical information activity by medical representatives. 1992.
Final report of Conference About Drugs in the 21st Century. Tokyo, Japan: Planning Division, Pharmaceutical Affairs Bureau, Ministry of Health and Welfare; 1992.
Takaku F, et al. Interim Report of Research Group for Promotion of Appropriate Use of Drugs. Tokyo, Japan: Safety Division, Ministry of Health and Welfare; 1995.
Yamamoto M, Negi H, Tamura M, et al. The development and practical use of information systems in the pharmaceutical industry. Meth Inform Med. 1993;32:400–406.
Bauman, JH, Fuenes RJ. Drug information at Glaxo Inc. Drug Inf J. 1989;23:95–103.
Yamamoto M, Onaka Y, Hirai T, et al. Drug information in the Japanese pharmaceutical industry: Analysis of eight-year investigation. Drug Inf J. 1995;29:1201–1209.
Cyberspace Revolution. Nikkei Sangyo. April 11, 1996; 19.